Babies R Us attempts comeback, plans to open store at American Dream mall in New Jersey

Babies R Us attempts comeback, plans to open store at American Dream mall in New Jersey


A shopping cart sits in the parking lot at a Babies “R” Us store on January 24, 2018 in Chicago, Illinois.

Scott Olson | Getty Images

Babies R Us is trying to make a comeback. 

The baby product retailer, which went out of business in 2018, will open a new flagship store this summer at the American Dream mega mall in New Jersey, its new owners announced Tuesday.

“Since acquiring both the Babies R Us and Toys R Us brands in 2021, our mission has been laser-focused on bringing them back to America,” Yehuda Shmidman, CEO of WHP Global, said in a news release. WHP Global, a brand management firm, owns the retailer’s parent company, Tru Kids. 

“Our plan to open Babies R Us at American Dream in the coming months is a huge milestone in the return of Babies R Us to the U.S.A., and it sets the stage for a national rollout of Babies R Us in the future,” Shmidman said.

American Dream, which has had its own struggles, is located near MetLife Stadium, about 10 miles outside of New York City.

American Dream megamall and entertainment complex in East Rutherford, N.J. After more than 17 years in the making, it finally opened October 25, 2019. Then came the coronoavirus pandemic.

Timothy A. Clary | AFP | Getty Images

Since acquiring Tru Kids in 2021, WHP Global has been on a mission to bring the beloved Toys R Us and Babies R Us brands back to life. 

In 2021, Macy’s announced a partnership with WHP Global to open 400 new Toys R Us outposts inside their department stores across the country and sell their products online. 

A new Toys R Us flagship was opened later that year, also at American Dream. 

The famed toy and baby retailer filed for Chapter 11 bankruptcy in 2017 after Tru Kids struggled to pay off its 12-year-old debt and compete with rising e-commerce platforms. 

The following year, the brand failed to restructure itself after a crippling 2017 holiday season and moved forward with liquidation, closing over 800 shops and selling inventory at up to 95% discounts. 

The new Babies R Us outpost will be a “one-stop-shop for all things baby.” In addition to the typical line of merchandise, it will offer customers a range of interactive experiences, including a stroller test track, photo-op station and a wishing tree. 

The flagship will also bring back the brand’s baby registry lounge, nursery design center with room set displays, learning center and a comfort zone for feeding or changing a baby while on-the-go.

–CNBC’s Melissa Repko contributed to this report.



Source

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored
Business

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026. Arman Onal | Anadolu | Getty Images The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus. The agency said the risk […]

Read More
These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More